Engflag

Acemax

Quick links to important sections

Acemax

Acemax_SL

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acemax

What is Acemax? Factual Overview

Property Description
Active Ingredient Acetazolamide, Lecithin, Omega-3 Fatty Acids, Vitamins (A, C, E), Minerals (Selenium, Zinc)
Form Oral Solid Dosage (Capsule or Tablet)
Pharmacological Class Carbonic Anhydrase Inhibitor and Multinutrient Antioxidant Complex
General Purpose Fluid and Pressure Regulation; Cellular Fortification
Origin Synthetic and Natural/Derived Combination

What Type of Medicine is Acemax? (Identity and Classification)

Acemax is a specialized oral Combination Medicine that strategically pairs the prescription drug Acetazolamide with a comprehensive Multinutrient Antioxidant Complex. Its primary classification is as a Carbonic Anhydrase Inhibitor (CAI), a class of drugs recognized for managing fluid dynamics by inhibiting the enzyme carbonic anhydrase. The function of CAIs is to help regulate the body's acid-base balance and fluid secretion. This preparation is a unique blend of a Synthetic agent and several Natural/Derived components, typically administered in an Oral solid dosage form. This combination product is often specifically formulated for patient populations requiring support where pressure regulation and cellular stress management are both clinical priorities.

Composition: Acetazolamide and the Antioxidant Complex

The formulation centers on Acetazolamide, delivered alongside a structural and protective matrix that includes Lecithin, essential Omega-3 Fatty Acids (EPA and DHA), and critical micronutrients. The complete Antioxidant Complex provides Vitamin A, Vitamin C (Ascorbic Acid), Vitamin E (Tocopherols), Selenium, and Zinc. This specific combination is purposefully engineered to provide the therapeutic action of the CAI drug component alongside elements vital for cell membrane integrity and robust cellular defense. The therapeutic role of Acetazolamide involves influencing ocular and systemic fluid dynamics, helping to control fluid flow and pressure in specific areas of the body.

General Purpose: Dual Action for Pressure Management and Cellular Support

The general purpose of Acemax utilizes a dual-action approach to manage physiological challenges while promoting tissue health, a strategy used for providing comprehensive patient care. The Acetazolamide component facilitates Fluid and Pressure Regulation, a typical use scenario for CAIs, while the extensive nutrient matrix provides essential Cellular Fortification against oxidative stress. This formulation's core benefit is its ability to integrate the management of abnormal pressure dynamics with the protective, long-term support necessary for tissues vulnerable to chronic stress and metabolic imbalance, differentiating it from single-agent CAI medications.

Regulatory References

  1. NIH: StatPearls, Acetazolamide

What side effects are possible with Acemax?

Possible Side Effects and Safety Information for Acemax

Acemax, like all medications, is associated with a range of possible side effects documented in regulatory safety summaries. These reactions are typically categorized by the system-organ class affected, such as the nervous system, gastrointestinal tract, and blood/lymphatic system.

Common Adverse Reactions

Many patients experience side effects that are considered common (occurring in 1 out of 10 to 1 out of 100 people). These frequently include tingling or numbness (paresthesia), mild gastrointestinal upset, changes in taste perception, and drowsiness or dizziness. Fatigue and increased frequency of urination are also commonly reported.

Serious and Clinically Significant Risks

Regulatory agencies emphasize the potential for serious, though rare, adverse reactions, which require immediate medical attention. These include severe cutaneous adverse reactions (SCARs), such as Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), and severe allergic reactions (anaphylaxis). Additionally, the drug has a documented risk of blood dyscrasias (e.g., agranulocytosis) and severe hepatic injury (liver damage).

Safety Restrictions and Monitoring

The established safety profile necessitates specific usage restrictions. Acemax is generally contraindicated in individuals with severe kidney or liver disease, known allergies to the drug or sulfonamides, and certain electrolyte imbalances. For specific medical conditions, such as diabetes or a history of respiratory compromise, the drug must be used with caution. Long-term use requires regular monitoring of blood counts and electrolyte levels to detect potential toxicity early, underscoring the need for ongoing medical supervision to manage its inherent risks.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Acemax

Overdose Scope

Documented overdose presentations:

  • The official labeling indicates that overdose may be characterized by the development of an acidotic state, electrolyte imbalance, and central nervous effects.
  • In severe toxicity scenarios, manifestations such as anorexia, tachypnea, and lethargy have been reported.

Physiological systems affected (as stated in label):

  • Central Nervous System (CNS)
  • Electrolytic and Acid-Base (pH) Balance

Dose-related or exposure-related factors (if applicable):

  • A potentially life-threatening toxicity is documented when the drug is co-administered with high-dose aspirin.

Population-specific overdose notes (if applicable):

  • Patients with impaired renal function and geriatric patients are noted to have an increased risk of severe toxicity and metabolic acidosis.

Emergency-response statements (as written in official documents):

  • Treatment for overdose is required to be symptomatic and supportive.
  • Mandatory actions include restoring and maintaining electrolyte balance and acid-base balance (pH levels).

When immediate medical help is required (label-derived phrasing only):

  • Seek immediate medical attention upon the manifestation of any severe clinical signs, including those leading to coma or other life-threatening outcomes.

Overdose Classifications (High-Level)

Severity classification (as defined in official documents):

  • Potential for Severe and Life-threatening outcomes in specific toxicity contexts.

Regulatory basis (EMA / FDA / etc.):

  • FDA Prescribing Information / Official Regulatory Labeling.

Overdose-context constraints (as defined in official documents):

  • No specific antidote is known. Continuous monitoring of serum electrolyte and blood pH levels is required.

Resulting overdose structure

Official overdose statements:

  • No specific antidote is known for this overdose.
  • Overdose may result in electrolyte imbalance and the development of an acidotic state.
  • Coma and death have been reported in scenarios involving the co-administration of the drug with high-dose aspirin.

Connection to the overall overdose profile (2–4 sentences): The official regulatory documents define the overdose profile by focusing on the expected physiological derangement—the development of an acidotic state—and subsequent electrolyte imbalance. Given the explicit statement that no specific antidote is known, the required emergency actions center entirely on symptomatic and supportive treatment, with continuous monitoring of blood chemistry mandated. Urgent medical help must be sought for any severe manifestations reported in severe toxicity cases.

Therapeutic Uses of Acemax

What Acemax Treats: Main Uses and Benefits

Acemax is commonly used to help with conditions characterized by systemic imbalance related to fluid pressure, such as Glaucoma and Idiopathic Intracranial Hypertension. The primary therapeutic support involves pressure moderation, which helps maintain stability for sensitive tissues and contributes to functional stability by easing symptoms related to heightened physiological activity. The drug is used as an adjunctive treatment for various forms of glaucoma and addresses systemic imbalance related to fluid retention.

The medication is relevant for managing symptoms that may become intense or disruptive across multiple domains, including supporting neurological stability to help control specific seizure types and offering prophylactic relief for the symptoms of Acute Mountain Sickness when ascending to high altitudes. It is also applied in addressing excess systemic fluid retention (edema), which supports comfort by easing associated swelling and discomfort.

“The support provided may assist with maintaining functional stability when symptoms are more noticeable.”

Quick Fact: Relief for Pressure-Related Symptoms

The medication assists with managing the overall symptom load by addressing symptoms related to systemic imbalance in conditions that involve recurrent or episodic manifestations, thereby helping to improve day-to-day comfort.

Regulatory References

  1. NIH DailyMed official labeling for Acetazolamide

Eligibility and Restrictions for Use

Who Can and Cannot Use Acemax?

The population eligibility for Acemax is strictly defined by regulatory documents governing its prescription component, Acetazolamide.

Absolute Contraindications

Acemax is contraindicated and must not be used in patients with the following conditions:

  • Documented hypersensitivity to Acetazolamide or to sulfonamide derivatives.
  • Marked kidney disease or dysfunction or marked liver disease, including hepatic cirrhosis.
  • Pre-existing severe electrolyte imbalances, specifically depressed sodium (hyponatremia) or potassium (hypokalemia) serum levels.
  • Hyperchloremic acidosis or suprarenal gland failure (Adrenocortical insufficiency).
  • For long-term use, patients with chronic non-congestive angle-closure glaucoma are excluded.

Population Restrictions

Group Official Regulatory Status
Pediatric Use Safety and effectiveness are not established in the general pediatric population.
Geriatric Use Use requires caution and dose adjustment due to the greater frequency of decreased organ function.
Pregnancy Not recommended during the first trimester. Use only if the potential benefit outweighs the potential risk (FDA Category C).
Renal Impairment Use requires caution and dosage adjustment. Avoidance is typically advised in cases of severe impairment.

What should I know about interactions with other medicines?

Acemax (which may contain aceclofenac, an NSAID, or acetazolamide, a carbonic anhydrase inhibitor) can interact with a variety of other medicines, potentially altering the effect of one or both drugs or increasing the risk of adverse reactions.

It is essential to inform your doctor or pharmacist about all prescription, over-the-counter, and herbal medicines you are currently taking.

Key Drug Interactions

Interacting Medicine Type Potential Interaction Risk Level
Other NSAIDs (e.g., ibuprofen, naproxen, aspirin) Increased risk of gastrointestinal bleeding and kidney problems. Major/Moderate
Anticoagulants (e.g., warfarin, heparin) Increased risk of bleeding. Close monitoring is necessary. Major
Diuretics (Water Pills) May reduce the blood pressure-lowering effect and increase the risk of kidney damage, especially when combined with an ACE inhibitor component. Moderate/Major
Lithium Acemax can cause an increase in lithium blood levels, leading to toxicity. Major
Antihypertensives (Blood Pressure Medicines) The blood pressure-lowering effect may be reduced. Moderate
Corticosteroids (e.g., prednisolone) Increased risk of gastrointestinal ulcers and bleeding. Moderate

Additionally, Acemax can affect the blood glucose-lowering effects of antidiabetic medicines. For formulations containing an NSAID, consumption of alcohol is strongly discouraged due to an elevated risk of stomach bleeding and liver damage. Regular blood tests for kidney function and electrolyte levels (such as potassium) may be required when taking Acemax concurrently with certain interacting medications.

Mechanism of Action

The primary action of Acemax targets the enzyme Carbonic Anhydrase (CA), which is crucial for generating bicarbonate ( HCO3^-) ions. By acting as an inhibitor of this enzyme in the choroid plexus and ciliary body, the drug suppresses the active transport of ions. This molecular cascade subsequently reduces the production and secretion of cerebrospinal fluid (CSF) and aqueous humor, leading directly to the physiological effect of lowering fluid pressure within these closed compartments. The complementary mechanism involves the Multinutrient Antioxidant Complex. Omega-3 Fatty Acids and Lecithin are incorporated into cell membranes, altering their structural properties, while the antioxidants scavenge Reactive Oxygen Species (ROS). This mechanism prevents lipid peroxidation and contributes to cellular structural stability. The synergy is defined by fluid-dynamic modulation working alongside structural membrane support. However, the primary mechanism is self-limiting: increased renal bicarbonate excretion reduces the CA substrate, limiting the ongoing reduction of ion and water reabsorption.

Dosage and Administration Information

How to Use Acemax

Acemax is administered based on established dosage guidelines for its active prescription component, Acetazolamide, and its use is dictated by the specific clinical scenario. The medication is available in both oral forms, including immediate-release tablets and extended-release capsules, and as a powder for intravenous (IV) injection for settings requiring rapid action. The intravenous route is the preferred non-oral administration method.

Standard Administration and Dosing

The established dosage range for chronic conditions, such as Glaucoma, is typically 250 mg to 1000 mg per 24 hours. Doses exceeding 250 mg per day are commonly given in divided intervals to maintain consistent levels. For prophylaxis against Acute Mountain Sickness, administration is generally started 24 to 48 hours before ascent and continued for at least 48 hours while at high altitude.

Usage Pattern Administration Rule
Form Restriction Extended-Release capsules must be swallowed whole and not crushed or chewed.
Timing & Food The oral dose may be taken with or without food.
Special Use For diuresis, instructions often support cyclic or intermittent use (e.g., alternating days) to maintain effectiveness.

Population-Specific Use

High-level guidance for older adults recommends using the lowest effective dose due to potential changes in renal function. For pediatric use in managing seizures, dosing is based on weight, with typical amounts ranging from 8 to 30 mg/kg per day in divided doses, not to exceed 750 mg daily. If a routine dose is missed, patients are instructed not to take a double dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acemax

Evidence for Pressure Moderation in Glaucoma

The research exploring the use of the primary component of Acemax in evaluating its effects on eye pressure primarily involves Randomized Controlled Trials (RCTs) and Comparative Studies. These trials were used to examine its role in conditions characterized by elevated Intraocular Pressure (IOP). Studies examined adult populations, often in situations requiring temporary fluid and pressure evaluation, such as before surgery or during acute episodes. Research describes patterns of change in IOP measurements when the CAI component was studied against a placebo.

However, the research base for this component has focused on evaluating its effect in acute or short-term clinical contexts. Long-term outcomes for using the oral form of this component for chronic, day-to-day pressure management are not as well characterized in the regulatory research record.

Clinical Research for Idiopathic Intracranial Hypertension (IIH)

Clinical research into the use of the CAI component for Idiopathic Intracranial Hypertension (IIH) includes definitive, large-scale Multicenter, Double-blind, Randomized, Placebo-Controlled Trials. These studies focused on patients whose condition involved periods of heightened symptom activity, specifically aiming to measure functional changes. The definitive trial data reported measured differences in visual function and markers of brain pressure in the group receiving the CAI component compared to the placebo group over a six-month period. Studies also described measured changes related to Papilledema (swelling of the optic nerve).

Studies for Prophylaxis of Acute Mountain Sickness (AMS)

The evidence base for using the CAI component in studies exploring how to reduce the incidence of Acute Mountain Sickness (AMS) is derived from numerous Randomized, Placebo-Controlled Trials synthesized into Systematic Reviews and Meta-analyses. Studies described changes measured in the groups receiving the drug component for prophylaxis when compared to placebo groups. The certainty remains low regarding the use of this component for addressing AMS once symptoms have already become noticeable. Research is limited regarding the specific role of the Antioxidant Complex in the clinical outcomes related to AMS prophylaxis.

Key Studies & References

  1. Acetazolamide: Drug information. NIH StatPearls
  2. DailyMed: Acetazolamide Official Labeling (e.g., Tablet/Capsule prescribing information)

Frequently Asked Questions (FAQ)

Common questions about Acemax (FAQ)

Q: What is the main reason doctors prescribe Acemax?

A: The active component of Acemax is officially approved for helping manage fluid dynamics and pressure in certain conditions. Official documentation indicates that it is used for addressing glaucoma (a condition affecting eye pressure), some types of convulsive disorders, and as a preventative measure for acute mountain sickness.

Q: Is Acemax a type of antibiotic or pain reliever?

A: Acemax's main prescription component is classified as a carbonic anhydrase inhibitor. Its classification as a carbonic anhydrase inhibitor defines its therapeutic purpose. It is officially described as a nonbacteriostatic sulfonamide derivative, which means it is chemically related to, but does not function as, an antibiotic.

Q: How long does it typically take for Acemax to start working?

A: Based on official pharmacological data, the active component generally reaches its maximum concentration in the bloodstream approximately 1 to 4 hours after it is taken orally. This timeframe is consistent with the drug's pharmacological profile.

Q: Can Acemax affect my mood or sleep?

A: Official adverse reaction lists document that the active component of Acemax may be associated with drowsiness and changes in the nervous system. These documented side effects include confusion or difficulty concentrating.

Q: Is there a generic version of Acemax available?

A: The primary component, Acetazolamide, is a well-established medicine that is widely available in generic form. Generic versions are generally available as oral tablets and powder for injection.

Q: Can I take Acemax while pregnant or breastfeeding?

A: Official warnings state that use during the first trimester of pregnancy is generally not recommended. Regarding breastfeeding, limited data suggests that only low levels of the drug may pass into the milk. Regulatory sources acknowledge the potential for metabolic effects in the infant and note that data is limited.

Q: Why do some people need to take Acemax for many months?

A: The active component is officially indicated for the management of chronic conditions, such as certain types of glaucoma and convulsive disorders. These conditions typically require ongoing, long-term therapeutic management.

Q: Is Acemax known to cause dizziness or problems with driving?

A: Official adverse reaction reports indicate that the medicine may cause symptoms such as drowsiness, dizziness, or blurred vision. Due to the potential for these effects, it is documented that the ability to drive or operate machinery may be impaired.

Q: Is it normal to experience a metallic taste after taking Acemax?

A: Regulatory documentation lists a metallic taste in the mouth or a general change in taste perception as a documented adverse reaction associated with the active component.

Q: Why is Acemax sometimes prescribed for uses other than the main one?

A: Beyond the primary indications, the active component is also formally indicated for other specific uses backed by research. These include as a preventative measure for acute mountain sickness (AMS) and in the management of idiopathic intracranial hypertension (IIH).

Q: Are there specific times of day when Acemax is better to take?

A: Official guidance indicates that for certain uses, such as promoting fluid excretion (diuresis), the starting dose may be taken once daily in the morning. Doses that exceed 250 mg are commonly administered in divided doses.

Q: Is it true that Acemax can change the color of my urine?

A: Official product information notes that the active component may interact with laboratory tests and can lead to an increased level of crystals in the urine. This physiological effect may be associated with changes in urine appearance.

Q: Does Acemax affect blood pressure?

A: Studies indicate that the active component, Acetazolamide, can lead to a reduction in blood pressure. This effect has been observed in clinical research involving patients with hypertension (high blood pressure) and obstructive sleep apnea.

Q: Is Acemax chemically related to other well-known drugs?

A: The primary component is officially described as a derivative of nonbacteriostatic sulfonamide drugs. Regulatory documents caution that because of this classification, patients with an allergy to other sulfonamide derivatives may have a possibility of cross-sensitivity.

Q: How long does Acemax stay in my system after I stop taking it?

A: Based on pharmacological data, the active component of Acemax has a plasma half-life of approximately 6 to 9 hours. This figure provides a pharmacokinetic reference point for how long the substance remains in the body.

Q: What is the official classification of Acemax (e.g., controlled substance)?

A: The active component, Acetazolamide, is not classified as a controlled substance by the U.S. Drug Enforcement Administration (DEA) or equivalent international agencies.

Q: Can Acemax cause skin rashes or sensitivity to the sun?

A: Official adverse event reports state that skin rashes have been reported. Furthermore, the drug is documented to have caused photosensitivity, which is an increased sensitivity or reaction to sunlight.

Q: Why do doctors refer to a 'Black Box Warning' for Acemax?

A: Although the FDA label for the active component does not contain a formal 'Black Box Warning,' it includes a prominent WARNINGS section. This section details rare but potentially fatal reactions common to sulfonamides, such as Stevens-Johnson Syndrome and severe blood disorders, which require careful monitoring.

Q: Does Acemax work immediately, or does it build up in the body?

A: The active component is a potent enzyme inhibitor that acts specifically on carbonic anhydrase. The drug's action as a potent enzyme inhibitor may be associated with relatively early therapeutic effects, such as a documented drop in intraocular pressure.

Q: What are the typical symptoms of an Acemax overdose?

A: While a specific list of overdose symptoms is not explicitly provided in the official warnings, high doses of the active component may lead to an increased incidence of certain side effects. These can include drowsiness, a tingling or numbness sensation (paresthesia), appetite loss (anorexia), rapid breathing (tachypnea), or severe metabolic acidosis.

How should Acemax be stored and disposed of?

How to Store and Dispose of Acemax

The storage of Acemax (Acetazolamide and Multinutrient Antioxidant Complex) must strictly follow the conditions detailed in the official labeling to maintain product stability.

Official Storage and Handling

Detail Requirement
Temperature Range Controlled Room Temperature: 20 C to 25 C (68 F to 77 F). Excursions up to 30 C are permitted.
Container & Protection Store in a tight, light-resistant container, kept tightly closed. The medicine must be protected from moisture and excessive heat. Do not freeze.
Child Safety KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Disposal Requirements

Unused or expired Acemax should be disposed of through a drug take-back program or an authorized collection site. If a take-back program is unavailable, the product may be mixed with an unappealing substance, placed in a sealed bag, and discarded with household trash. Personal information on the packaging should be removed before disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Acemax found in:

A-Z Index: